Gy∙cm2 is used for estimating stochastic risk to patients while mGy relates to tissue reaction. Gy∙cm2 is a unit historically known as dose-area product (DAP) and currently named kerma-area product ...

Low dose birth control pills may have fewer side effects compared with older, higher-dose ones, but certain groups may still have increased health risks. If they aren’t taken correctly ...

Hikma will acquire parts of Xellia's US finished dosage form business and assets. According to its statement this will ...

Hikma Pharmaceuticals PLC, which is headquartered in London, plans to acquire parts of Xellia Pharmaceuticals' finished dosage form business and assets, including a commercial portfolio and ...

Not for use in untreated open-angle glaucoma. Reevaluate periodically. Change dose gradually. Withdrawal symptoms on abrupt cessation or dose reduction. Suicidal ideation. Psychosis. Mania.

Indian drugmaker Hikma has agreed in principle to a $150 million settlement to resolve lawsuits claiming that it contributed to the opioid crisis in the US, which could allow it to put the ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100 ...

May be antagonized by oral contraceptives (may need to increase lorazepam dose). May be potentiated by probenecid or valproate (reduce lorazepam dose by 50%). Lorazepam interacts with the γ ...

Hikma Pharmaceuticals' corporate investment arm Hikma Ventures has launched a $30 million digital health fund in Jordan, focusing on therapeutic and diagnostic start-ups. The company's roots are ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...